LONDON (Alliance News) - Dettol and Nurofen maker Reckitt Benckiser
Group PLC Wednesday reported higher profit for 2014, despite a fall in
revenue, helped by price increases and its cost optimisation
initiatives, as well as like-for-like revenue growth in the fourth
quarter.
The British consumer goods giant reported an adjusted operating profit of GBP2.19 billion for 2014, excluding its RB Pharmaceuticals business, compared with GBP2.14 billion last year, up 11% at constant currency rates and 2% growth at actual rates.
Its pretax profit for the year came in at GBP2.13 billion, up from GBP1.86 billion in 2013.
Net revenue, excluding RB Pharmaceuticals, came in at GBP8.84 billion, compared with a restated revenue figure of GBP9.27 billion in 2013. The decline marked a 5% fall at actual rates, hit by the strength of sterling, however Reckitt said growth would have been 4% if currency rates had stayed unchanged.
Read more at Click here / www.trade4x.net
The British consumer goods giant reported an adjusted operating profit of GBP2.19 billion for 2014, excluding its RB Pharmaceuticals business, compared with GBP2.14 billion last year, up 11% at constant currency rates and 2% growth at actual rates.
Its pretax profit for the year came in at GBP2.13 billion, up from GBP1.86 billion in 2013.
Net revenue, excluding RB Pharmaceuticals, came in at GBP8.84 billion, compared with a restated revenue figure of GBP9.27 billion in 2013. The decline marked a 5% fall at actual rates, hit by the strength of sterling, however Reckitt said growth would have been 4% if currency rates had stayed unchanged.
Read more at Click here / www.trade4x.net
No comments:
Post a Comment